These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16980215

  • 1. Chemokine inhibition in inflammatory arthritis.
    Tak PP.
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):929-39. PubMed ID: 16980215
    [Abstract] [Full Text] [Related]

  • 2. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 3. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
    Iwamoto T, Okamoto H, Toyama Y, Momohara S.
    FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
    [Abstract] [Full Text] [Related]

  • 4. Chemokine receptor expression in rat adjuvant-induced arthritis.
    Haas CS, Martinez RJ, Attia N, Haines GK, Campbell PL, Koch AE.
    Arthritis Rheum; 2005 Dec; 52(12):3718-30. PubMed ID: 16320322
    [Abstract] [Full Text] [Related]

  • 5. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial.
    Vergunst CE, Gerlag DM, Lopatinskaya L, Klareskog L, Smith MD, van den Bosch F, Dinant HJ, Lee Y, Wyant T, Jacobson EW, Baeten D, Tak PP.
    Arthritis Rheum; 2008 Jul; 58(7):1931-9. PubMed ID: 18576354
    [Abstract] [Full Text] [Related]

  • 6. The role of chemokines in rheumatoid arthritis and osteoarthritis.
    Vergunst CE, van de Sande MG, Lebre MC, Tak PP.
    Scand J Rheumatol; 2005 Jul; 34(6):415-25. PubMed ID: 16393761
    [Abstract] [Full Text] [Related]

  • 7. Targeting the chemokine network in renal inflammation.
    Eis V, Vielhauer V, Anders HJ.
    Arch Immunol Ther Exp (Warsz); 2004 Jul; 52(3):164-72. PubMed ID: 15247883
    [Abstract] [Full Text] [Related]

  • 8. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
    Haringman JJ, Oostendorp RL, Tak PP.
    Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
    [Abstract] [Full Text] [Related]

  • 9. Novel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trials.
    Gerlag DM, Tak PP.
    Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):311-23. PubMed ID: 18455687
    [Abstract] [Full Text] [Related]

  • 10. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, Bijlsma JW, Lafeber FP.
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [Abstract] [Full Text] [Related]

  • 11. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z, Koch AE, Tak PP.
    Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
    [Abstract] [Full Text] [Related]

  • 12. T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis.
    Beech JT, Andreakos E, Ciesielski CJ, Green P, Foxwell BM, Brennan FM.
    Arthritis Res Ther; 2006 Sep; 8(6):R168. PubMed ID: 17101049
    [Abstract] [Full Text] [Related]

  • 13. New drug targets in rheumatoid arthritis: focus on chemokines.
    Shadidi KR.
    BioDrugs; 2004 Sep; 18(3):181-7. PubMed ID: 15161335
    [Abstract] [Full Text] [Related]

  • 14. [Treatment for rheumatoid arthritis by chemokine blockade].
    Nanki T.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Sep; 39(3):172-80. PubMed ID: 27320932
    [Abstract] [Full Text] [Related]

  • 15. Chemokines in joint disease: the key to inflammation?
    Haringman JJ, Ludikhuize J, Tak PP.
    Ann Rheum Dis; 2004 Oct; 63(10):1186-94. PubMed ID: 15082471
    [Abstract] [Full Text] [Related]

  • 16. Macrophages and their products in rheumatoid arthritis.
    Szekanecz Z, Koch AE.
    Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
    [Abstract] [Full Text] [Related]

  • 17. [Blockade of chemokines in chronic inflammatory diseases].
    Haringman JJ, Tak PP.
    Ned Tijdschr Geneeskd; 2004 Sep 04; 148(36):1760-4. PubMed ID: 15495938
    [Abstract] [Full Text] [Related]

  • 18. Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.
    van der Heijden JW, Oerlemans R, Dijkmans BA, Qi H, van der Laken CJ, Lems WF, Jackman AL, Kraan MC, Tak PP, Ratnam M, Jansen G.
    Arthritis Rheum; 2009 Jan 04; 60(1):12-21. PubMed ID: 19116913
    [Abstract] [Full Text] [Related]

  • 19. [Role of chemokines in the pathogenesis of rheumatoid arthritis].
    Nanki T.
    Nihon Rinsho; 2005 Jan 04; 63 Suppl 1():195-9. PubMed ID: 15799345
    [No Abstract] [Full Text] [Related]

  • 20. Chemokines and their receptors in rheumatoid arthritis: future targets?
    Koch AE.
    Arthritis Rheum; 2005 Mar 04; 52(3):710-21. PubMed ID: 15751074
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.